4//SEC Filing
Bjarke Henric Bjorn 4
Accession 0001209191-21-021483
CIK 0001693011other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 5:56 PM ET
Size
5.5 KB
Accession
0001209191-21-021483
Insider Transaction Report
Form 4
Bjarke Henric Bjorn
See Remarks
Transactions
- Award
Stock option (right to buy)
2021-03-04+51,000→ 51,000 totalExercise: $19.78Exp: 2031-03-03→ Common Stock (51,000 underlying)
Footnotes (1)
- [F1]The option was granted on March 4, 2021. The shares underlying the option are scheduled to vest in equal monthly installments from March 4, 2021 through March 4, 2025.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001652179
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 5:56 PM ET
- Size
- 5.5 KB